Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

This article explores how challenges such as sequence optimization, immune activation and off-target effects are being ...

A new study identifies a mechanism for how COVID vaccines may, in infrequent cases, drive heart inflammation, a condition ...

Arrowhead Pharmaceuticals (ARWR) just started dosing patients in its Phase 1/2a trial for ARO-MAPT, an RNA interference therapy aimed at tauopathies like Alzheimer’s, and the stock has been reacting ...

Scientists at Northwestern University have developed the fastest test yet for diagnosing hepatitis C virus (HCV). The highly ...

This second venture capital (VC) led financing follows a $4m Series A raise last year and involved existing investors ...

The CDC says an Idaho man who donated organs was infected with rabies before his death. Doctors were not aware of the ...

Financing includes participation from leading institutional investors including Janus Henderson Investors, Brahma Capital, Biotrack Capital, Cormorant Asset Management, OrbiMed, Plaisance Capital ...

Dyne Therapeutics, Inc.’s 2026 outlook with key DYNE-101/251 data, FDA submission plans, and extended cash runway. Click for ...

As life expectancy continues to climb globally, the focus of many people has moved from longevity alone to living in good ...

A Michigan man died from a kidney transplant due to a believed rabies virus infection - which also killed the Idaho donor ...

The test is now ordered by breast surgeons or radiation oncologists in more than 85% of the top 50 U.S. cancer centers. “DCISionRT is becoming the standard of care for physicians and patients ...